User contributions
For
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)
- 08:41, 17 April 2017 (diff | hist) . . (-1,931) . . Acetyl L-carnitine (ALCAR)
- 08:36, 17 April 2017 (diff | hist) . . (-1,914) . . Acetyl L-carnitine (ALCAR)
- 08:05, 17 April 2017 (diff | hist) . . (-5,686) . . Acetyl L-carnitine (ALCAR)
- 07:20, 17 April 2017 (diff | hist) . . (-4,676) . . Acetyl L-carnitine (ALCAR)
- 07:03, 17 April 2017 (diff | hist) . . (+85) . . Acetyl L-carnitine (ALCAR)
- 06:13, 17 April 2017 (diff | hist) . . (-12,433) . . 5-HTP
- 06:10, 17 April 2017 (diff | hist) . . (+58) . . 5-HTP
- 22:18, 16 April 2017 (diff | hist) . . (+36) . . 5-HTP
- 22:04, 16 April 2017 (diff | hist) . . (+26) . . 5-HTP
- 21:57, 16 April 2017 (diff | hist) . . (+163) . . N Category:Supplement data pages (Created page with "A separate page will be written for each substance, with data collected from different reliable sources. It is important that references are included for all data.")
- 21:49, 16 April 2017 (diff | hist) . . (+36) . . 5-HTP
- 18:49, 16 April 2017 (diff | hist) . . (+96) . . N Category:Supplement summary (Created page with "A summary table of the information found in more detail in data pages for individual substances.") (current)
- 18:41, 16 April 2017 (diff | hist) . . (+33) . . Information on nutritional supplements people with ALS have been taking
- 13:00, 16 April 2017 (diff | hist) . . (+23) . . Ammonium hypothesis
- 12:56, 16 April 2017 (diff | hist) . . (+169) . . N Ammonium hypothesis (Created page with " Bhavin Parekh has presented a hypothesis that some forms of ALS could be caused by chronic excess ammonia in the body. {{#pmid:27785351|parekh2015}} == References ==")
- 19:01, 14 February 2017 (diff | hist) . . (+377) . . Calcium homeostasis
- 17:53, 14 February 2017 (diff | hist) . . (+6) . . Calcium homeostasis
- 17:52, 14 February 2017 (diff | hist) . . (+810) . . N Calcium homeostasis (Created page with "''The major mechanisms contributing to the degeneration of motor neurons have already been disclosed and characterized, including excitotoxicity, oxidative stress, mitochondri...")
- 12:22, 14 February 2017 (diff | hist) . . (+79) . . Information on nutritional supplements people with ALS have been taking
- 12:17, 14 February 2017 (diff | hist) . . (+40) . . Information on nutritional supplements people with ALS have been taking
- 21:28, 13 February 2017 (diff | hist) . . (+1,797) . . Methylcobalamin
- 20:48, 13 February 2017 (diff | hist) . . (+686) . . N Vitamin D3 (Created page with " == ALSUntangled evaluation == ''At this time, there is evidence that PALS, like those with other chronic illnesses, are at increased risk for vitamin D deficiency. It is the...")
- 16:36, 13 February 2017 (diff | hist) . . (+577) . . Nerves that resist destruction
- 16:25, 13 February 2017 (diff | hist) . . (+40) . . Key concepts in ALS
- 16:03, 13 February 2017 (diff | hist) . . (-15,378) . . Inosine
- 16:01, 13 February 2017 (diff | hist) . . (+25) . . Inosine
- 15:56, 13 February 2017 (diff | hist) . . (+21) . . Inosine
- 15:52, 13 February 2017 (diff | hist) . . (+23) . . Inosine
- 15:48, 13 February 2017 (diff | hist) . . (+28) . . Inosine
- 15:44, 13 February 2017 (diff | hist) . . (+31) . . Inosine
- 15:40, 13 February 2017 (diff | hist) . . (+33) . . Inosine
- 15:33, 13 February 2017 (diff | hist) . . (+516) . . Inosine
- 15:22, 13 February 2017 (diff | hist) . . (+392) . . MitoQ
- 15:16, 13 February 2017 (diff | hist) . . (+125) . . N MitoQ (Created page with "Information on nutritional supplements people with ALS have been taking == ALSUntangled evaluation == == References ==")
- 15:14, 13 February 2017 (diff | hist) . . (+76) . . Spirulina
- 15:09, 13 February 2017 (diff | hist) . . (-10,227) . . Luteolin
- 14:21, 13 February 2017 (diff | hist) . . (+26) . . Luteolin
- 13:55, 13 February 2017 (diff | hist) . . (+33) . . Luteolin
- 13:48, 13 February 2017 (diff | hist) . . (+844) . . Luteolin
- 13:34, 13 February 2017 (diff | hist) . . (+388) . . N Spirulina (Created page with " == ALSUntangled evaluation == ''At this time, ALSuntangled finds no evidence that Spirulina is effective for ALS and there appear to be real and theoretical toxicities that...")
- 13:12, 13 February 2017 (diff | hist) . . (+23) . . Key concepts in ALS
- 13:10, 13 February 2017 (diff | hist) . . (+24) . . Neuroinflammation
- 13:07, 13 February 2017 (diff | hist) . . (+995) . . N Neuroinflammation (Created page with " ''Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing pr...")
- 11:50, 13 February 2017 (diff | hist) . . (+36) . . Loss of BBB integrity
- 11:31, 13 February 2017 (diff | hist) . . (+1,696) . . Loss of BBB integrity
- 10:11, 13 February 2017 (diff | hist) . . (+1,248) . . N Loss of BBB integrity (Created page with " ''Vascular pathology, including blood-brain/spinal cord barrier (BBB/BSCB) alterations, has recently been recognized as a key factor possibly aggravating motor neuron damage,...")
- 21:46, 12 February 2017 (diff | hist) . . (+2,315) . . Aberrant astrocytes
- 21:38, 12 February 2017 (diff | hist) . . (+22) . . Key concepts in ALS
- 21:32, 12 February 2017 (diff | hist) . . (+7) . . Aberrant astrocytes
- 21:26, 12 February 2017 (diff | hist) . . (+1,601) . . Aberrant astrocytes
- 20:34, 12 February 2017 (diff | hist) . . (+12) . . Aberrant astrocytes
- 20:31, 12 February 2017 (diff | hist) . . (+1,104) . . Aberrant astrocytes
- 19:34, 12 February 2017 (diff | hist) . . (+23) . . Aberrant astrocytes
- 19:32, 12 February 2017 (diff | hist) . . (+6) . . Aberrant astrocytes
- 19:28, 12 February 2017 (diff | hist) . . (+6) . . Aberrant astrocytes
- 19:26, 12 February 2017 (diff | hist) . . (+6) . . Aberrant astrocytes
- 19:23, 12 February 2017 (diff | hist) . . (+6) . . Aberrant astrocytes
- 19:20, 12 February 2017 (diff | hist) . . (+6) . . Aberrant astrocytes
- 19:18, 12 February 2017 (diff | hist) . . (+1,635) . . Aberrant astrocytes
- 19:13, 12 February 2017 (diff | hist) . . (+1,999) . . Aberrant astrocytes
- 19:09, 12 February 2017 (diff | hist) . . (+1,790) . . Aberrant astrocytes
- 19:00, 12 February 2017 (diff | hist) . . (+1,516) . . N Aberrant astrocytes (Created page with " ''Amyotrophic Lateral Sclerosis (ALS) is a paradigmatic neurodegenerative disease, characterized by progressive paralysis of skeletal muscles associated with motor neuron de...")
- 18:51, 12 February 2017 (diff | hist) . . (+209) . . Nerves that resist destruction
- 18:42, 12 February 2017 (diff | hist) . . (+149) . . N Nerves that resist destruction (Created page with " [http://www.medfak.umu.se/english/about-the-faculty/news/newsdetailpage/eye-muscles-are-resilient-to-als.cid278428 Eye muscles are resilient to ALS]")
- 20:45, 16 January 2017 (diff | hist) . . (0) . . Key concepts in ALS
- 20:34, 16 January 2017 (diff | hist) . . (+18) . . Exosomes
- 20:32, 16 January 2017 (diff | hist) . . (+1,690) . . N Exosomes (Created page with "Key concepts in ALS *[https://en.wikipedia.org/wiki/Exosome_(vesicle) Wikipedia page] ''Cytoplasmic TDP-43 aggregation is a pathological hallmark of amyotrophic lateral...")
- 20:22, 16 January 2017 (diff | hist) . . (+15) . . Key concepts in ALS
- 17:01, 16 January 2017 (diff | hist) . . (+1,250) . . HspB8
- 16:36, 16 January 2017 (diff | hist) . . (+11) . . Key concepts in ALS
- 16:34, 16 January 2017 (diff | hist) . . (+13) . . Key concepts in ALS
- 16:33, 16 January 2017 (diff | hist) . . (+539) . . HspB8
- 11:21, 16 January 2017 (diff | hist) . . (+25) . . Stress granules
- 11:20, 16 January 2017 (diff | hist) . . (+25) . . HspB8
- 11:17, 16 January 2017 (diff | hist) . . (+23) . . Autophagy
- 11:14, 16 January 2017 (diff | hist) . . (+59) . . N Autophagy (Created page with " *[https://en.wikipedia.org/wiki/Autophagy Wikipedia page]")
- 11:09, 16 January 2017 (diff | hist) . . (+12) . . HspB8
- 11:02, 16 January 2017 (diff | hist) . . (+31) . . Key concepts in ALS
- 10:59, 16 January 2017 (diff | hist) . . (+39) . . HspB8
- 10:55, 16 January 2017 (diff | hist) . . (+6) . . HspB8
- 10:52, 16 January 2017 (diff | hist) . . (+6) . . HspB8
- 10:43, 16 January 2017 (diff | hist) . . (+1,718) . . HspB8
- 10:30, 16 January 2017 (diff | hist) . . (+6) . . HspB8
- 10:28, 16 January 2017 (diff | hist) . . (+1,436) . . HspB8
- 10:02, 16 January 2017 (diff | hist) . . (+18) . . HspB8
- 10:01, 16 January 2017 (diff | hist) . . (+1,818) . . N HspB8 (Created page with "''Aggregation of TAR-DNA-binding protein 43 (TDP-43) and of its fragments TDP-25 and TDP-35 occurs in amyotrophic lateral sclerosis (ALS). TDP-25 and TDP-35 act as seeds for T...")
- 07:17, 16 January 2017 (diff | hist) . . (+1,765) . . Stress granules
- 07:03, 16 January 2017 (diff | hist) . . (+1,981) . . Stress granules
- 21:46, 15 January 2017 (diff | hist) . . (-6) . . Stress granules
- 20:26, 15 January 2017 (diff | hist) . . (+8) . . Stress granules
- 20:23, 15 January 2017 (diff | hist) . . (+24) . . Key concepts in ALS
- 20:19, 15 January 2017 (diff | hist) . . (+12) . . Stress granules
- 20:15, 15 January 2017 (diff | hist) . . (0) . . Stress granules
- 20:11, 15 January 2017 (diff | hist) . . (+12) . . Stress granules
- 20:07, 15 January 2017 (diff | hist) . . (+6) . . Stress granules
- 20:02, 15 January 2017 (diff | hist) . . (0) . . Stress granules
- 19:56, 15 January 2017 (diff | hist) . . (+1,315) . . Stress granules
- 19:42, 15 January 2017 (diff | hist) . . (+57) . . Stress granules
- 19:38, 15 January 2017 (diff | hist) . . (+1,609) . . Stress granules
- 18:32, 15 January 2017 (diff | hist) . . (+631) . . Stress granules
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)